Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,232.00    -24.00 (-1.91%)
Bid:
1,232.00
Ask:
1,238.00
Spread: 6.00 (0.487%)
Market Cap: £564.58m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

AGM Statement

7 Sep 2017 07:00

RNS Number : 0194Q
Cohort PLC
07 September 2017
 

 07 September 2017

 

COHORT PLC

("Cohort" or "the Group")

 

AGM Statement & First Quarter Update

 

Cohort, the independent technology group, is today holding its Annual General Meeting. The Chairman, Nick Prest, will make the following remarks to the meeting:

 

"Cohort again improved its performance in the most recent financial year, achieving record adjusted operating profit. This result was driven primarily by a strong maiden contribution from EID and improved performance at MCL. In the course of the year, we acquired a controlling stake in EID, took our ownership of MCL to 100% and restructured SCS by transferring its operating divisions to MASS and SEA.

 

"Important contract awards announced since the final results in June include:

 

· EID to supply Integrated Communications Systems to the Portuguese Navy;

· SEA to provide Torpedo Launcher Systems for the Southeast Asian market; and

· MCL to supply further Hearing Protection and Communication Ancillaries to the UK MOD.

 

"Including these awards, the Group's order book stood at £149m as at 31 July 2017, underpinning a slightly higher proportion of our externally forecast revenue for the year compared to this time last year. Our pipeline of orders and expected renewals give us confidence that the overall performance for the year will be in line with the Board's expectations.

 

"The Group's net funds as at 31 August 2017 stood at £8.8m, slightly higher than that announced at the time of the final results in June. This is after the impact of the payment made in August of the final instalment of £2.5m to MCL's former shareholders under the terms of the acquisition agreement. 

 

"Our emphasis continues to be on driving further growth, supported by a continuing strong funding position. An improved closing order book position, taken together with orders received in the new financial year to date and a good pipeline of further prospects across the Group's divisions, provide a solid base for this year and beyond."

 

Ends 

 

For further information, please contact:

 

Cohort plc

 

0118 909 0390

Andrew Thomis, Chief ExecutiveSimon Walther, Finance Director

 

 

 

 

Investec Bank plc

 

020 7597 5970

Keith Anderson / Daniel Adams

 

 

 

 

 

MHP Communications Limited

 

020 3128 8100

Reg Hoare / Ollie Hoare

 

 

 

NOTES TO EDITORS

Cohort is the parent company of four innovative, agile and responsive businesses based in the UK and Portugal, providing a wide range of services and products for domestic and export customers in defence and related markets.

 

MASS is a specialist defence and technology business, focused on electronic warfare, information systems and cyber security.

www.mass.co.uk

 

MCL is an expert in the sourcing, design, integration and support of communications and surveillance technology for the defence and security markets.

www.marlboroughcomms.com

 

SEA is an advanced electronic systems and software house operating in the defence, transport and offshore energy markets.

www.sea.co.uk

 

EID designs and manufactures advanced communications systems for the defence and security markets.

www.eid.pt

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMSSIFDMFWSEIU
Date   Source Headline
1st Jun 202611:41 amRNSTotal Voting Rights
27th May 20267:00 amRNSFull Year Trading Update
26th May 20267:00 amRNSNotice of Full Year Trading Update
12th May 202610:46 amRNSHolding(s) in Company
1st May 20269:37 amRNSTotal Voting Rights
10th Apr 20263:58 pmRNSDirector/PDMR Shareholding
10th Apr 202612:35 pmRNSHolding(s) in Company
2nd Apr 20267:00 amRNSBlock Listing Six Monthly Return
1st Apr 202610:10 amRNSTotal Voting Rights
26th Mar 20267:00 amRNSContract Announcement
23rd Mar 20267:00 amRNSContract Announcement
2nd Mar 202611:57 amRNSTotal Voting Rights
25th Feb 20269:51 amRNSBlock Listing Six Monthly Return
20th Feb 20267:00 amRNSDirector/PDMR Shareholding
17th Feb 20263:41 pmRNSHolding(s) in Company
16th Feb 20267:00 amRNSDirector/PDMR Shareholding
4th Feb 20269:35 amRNSHolding(s) in Company
2nd Feb 20264:54 pmRNSTotal Voting Rights
30th Jan 20267:00 amRNSContract Wins
20th Jan 202612:40 pmRNSHolding(s) in Company
15th Jan 20267:00 amRNSInterim Report 2025
5th Jan 20269:00 amRNS-RInvestor Presentation via Equity Development
2nd Jan 202612:40 pmRNSTotal Voting Rights
22nd Dec 20259:00 amRNS-RInvestor Presentation via Engage Investor
22nd Dec 20259:00 amRNS-RInvestor Presentation via Engage Investor
15th Dec 202511:56 amRNSDirector/PDMR Shareholding
11th Dec 20257:00 amRNSDirector/PDMR Shareholding
10th Dec 20257:01 amRNSHalf Year Results
1st Dec 202512:20 pmRNSTotal Voting Rights
28th Nov 20257:00 amRNSNotice of Half Year Results
4th Nov 202511:59 amRNSTotal Voting Rights
27th Oct 20254:37 pmRNSDirector/PDMR Shareholding
16th Oct 202510:11 amRNSDirector/PDMR Shareholding
7th Oct 20253:15 pmRNSDirector/PDMR Shareholding
7th Oct 20257:00 amRNSMASS secures £15.7m countermeasures contract
2nd Oct 202511:03 amRNSBlock Listing Six Monthly Return
1st Oct 20259:53 amRNSTotal Voting Rights
25th Sep 20254:59 pmRNSResult of AGM
25th Sep 20257:00 amRNSAGM Statement
19th Sep 20255:12 pmRNSDirector/PDMR Shareholding
12th Sep 20257:00 amRNS-RInvestor Presentation
10th Sep 20253:21 pmRNSDirector/PDMR Shareholding
3rd Sep 202510:57 amRNSDirector/PDMR Shareholding
1st Sep 202511:05 amRNSTotal Voting Rights
26th Aug 20253:22 pmRNSBlock Listing Six Monthly Return
20th Aug 20253:56 pmRNSAnnual Report and Notice of Annual General Meeting
15th Aug 20253:35 pmRNSDirector/PDMR Shareholding
11th Aug 20255:10 pmRNSDirector/PDMR Shareholding
1st Aug 20254:16 pmRNSTotal Voting Rights
17th Jul 20259:49 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.